ES2012118A6 - Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos. - Google Patents

Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos.

Info

Publication number
ES2012118A6
ES2012118A6 ES8802831A ES8802831A ES2012118A6 ES 2012118 A6 ES2012118 A6 ES 2012118A6 ES 8802831 A ES8802831 A ES 8802831A ES 8802831 A ES8802831 A ES 8802831A ES 2012118 A6 ES2012118 A6 ES 2012118A6
Authority
ES
Spain
Prior art keywords
acid
water
fatty acid
polyol
insoluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8802831A
Other languages
English (en)
Inventor
Lorenz Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2012118A6 publication Critical patent/ES2012118A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE SOLUCIONES SOLIDAS DE COMPUESTOS FARMACEUTICAMENTE ACTIVOS, EN CONCRETO A BASE DE: A) UN COMPUESTO FARMACEUTICAMENTE ACTIVO, Y B) UN MONOESTER HIDROSOLUBLE DE UN ACIDO GRASO (C6-18) SATURADO O SIN SATURAR Y UN POLIOL, CARACTERIZADO PORQUE COMPRENDE: A) DISOLVER LOS COMPONENTES (A) Y (B) EN UN DISOLVENTE VOLATIL Y VOLATILIZAR EL DISOLVENTE; O B) LICUAR EL COMPONENTE (B) MEDIANTE FUSION, DISOLVER EL COMPONENTE (A) EN LA FUSION OBTENIDA Y SOLIDIFICAR LUEGO LA SOLUCION OBTENIDA POR ENFRIAMIENTO; Y C) RECUPERAR LA SOLUCION SOLIDA OBTENIDA.
ES8802831A 1987-09-15 1988-09-15 Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos. Expired - Lifetime ES2012118A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (1)

Publication Number Publication Date
ES2012118A6 true ES2012118A6 (es) 1990-03-01

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802831A Expired - Lifetime ES2012118A6 (es) 1987-09-15 1988-09-15 Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos.

Country Status (24)

Country Link
JP (1) JP3090666B2 (es)
KR (1) KR0131084B1 (es)
AT (1) AT395819B (es)
AU (1) AU628787B2 (es)
BE (1) BE1001204A5 (es)
CA (1) CA1338775C (es)
CH (1) CH683672A5 (es)
DK (1) DK175132B1 (es)
ES (1) ES2012118A6 (es)
FI (1) FI94837C (es)
FR (1) FR2620336B1 (es)
GB (1) GB2209671B (es)
GR (1) GR1002243B (es)
HU (1) HU205010B (es)
IE (1) IE61195B1 (es)
IL (1) IL87746A (es)
IT (1) IT1224886B (es)
LU (1) LU87335A1 (es)
MY (1) MY103769A (es)
NL (1) NL195094C (es)
NO (1) NO179434C (es)
NZ (1) NZ226163A (es)
PT (1) PT88492B (es)
SE (1) SE503279C2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GR1000466B (el) * 1989-01-28 1992-07-30 Sandoz Ag Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
ATE198041T1 (de) 1993-09-28 2000-12-15 Scherer Gmbh R P Herstellung von weichgelatinekapseln
WO1996014079A1 (de) 1994-11-03 1996-05-17 Arzneimittelwerk Dresden Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
PL190420B1 (pl) 1997-01-30 2005-12-30 Novartis Ag Twarda kapsułka żelatynowa zawierajaca kompozycjęfarmaceutyczną
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1558215A4 (en) * 2003-10-14 2007-09-12 Wockhardt Ltd STERILE GELIFYING AGENTS
JP5422871B2 (ja) * 2006-10-24 2014-02-19 不二製油株式会社 イソフラボン類組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE624258A (es) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (es) * 1966-11-22 1968-06-21
BE787842A (fr) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd Procede de preparation d'une suspension aqueuse de cristaux stables du type non beta d'esters d'acides gras superieurs du chloramphenicol
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤

Also Published As

Publication number Publication date
MY103769A (en) 1993-09-30
FR2620336B1 (fr) 1991-10-25
PT88492A (pt) 1988-10-01
LU87335A1 (fr) 1989-04-06
KR890004694A (ko) 1989-05-09
NL8802275A (nl) 1989-04-03
NO884052D0 (no) 1988-09-13
HUT49494A (en) 1989-10-30
GR1002243B (en) 1996-04-22
CH683672A5 (de) 1994-04-29
SE8803221L (sv) 1989-03-16
KR0131084B1 (ko) 1998-04-17
GB8821443D0 (en) 1988-10-12
DK175132B1 (da) 2004-06-14
NZ226163A (en) 1991-08-27
DK511188A (da) 1989-03-16
GB2209671A (en) 1989-05-24
PT88492B (pt) 1993-03-31
SE503279C2 (sv) 1996-05-13
IL87746A0 (en) 1989-02-28
AU628787B2 (en) 1992-09-24
NO179434C (no) 1996-10-09
FI94837B (fi) 1995-07-31
AU2217288A (en) 1989-04-27
AT395819B (de) 1993-03-25
IL87746A (en) 1992-07-15
GB2209671B (en) 1991-11-13
GR880100602A (el) 1989-06-22
NO884052L (no) 1989-03-16
FR2620336A1 (fr) 1989-03-17
NL195094C (nl) 2003-12-17
SE8803221D0 (sv) 1988-09-13
NO179434B (no) 1996-07-01
BE1001204A5 (fr) 1989-08-16
FI884192A0 (fi) 1988-09-13
JP3090666B2 (ja) 2000-09-25
HU205010B (en) 1992-03-30
IE61195B1 (en) 1994-10-19
FI884192A (fi) 1989-03-16
IT1224886B (it) 1990-10-24
CA1338775C (en) 1996-12-10
DK511188D0 (da) 1988-09-14
FI94837C (fi) 1995-11-10
JPH01151526A (ja) 1989-06-14
ATA224988A (de) 1992-08-15
IE882772L (en) 1989-03-15
IT8848349A0 (it) 1988-09-14

Similar Documents

Publication Publication Date Title
ES2012118A6 (es) Procedimiento de obtencion de soluciones solidas de compuestos farmaceuticamente activos.
US5500416A (en) Percutaneous absorption promoting agent and dermatologic preparation containing the same
US6565879B1 (en) Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
ZA871911B (en) New pharmaceutical preparations with extended release
CA2132277A1 (en) Injection device
DK280884A (da) Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling
MY109875A (en) Novel formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight surfactants.
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
IL72034A0 (en) Oral pharmaceutical compositions containing antidiabetic agents
CA2215327A1 (en) Formulations for lipophilic compounds
FI854167A0 (fi) Mun- och tandvaordsmedel.
JPS57146722A (en) Pharmaceutical preparation having improved absorption
NZ332497A (en) Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent
MX173572B (es) Matriz de espuma activa artropodicidalmente, estable, soluble en agua y metodo para su preparacion
JPS5675423A (en) Physiologically active high polymer substance-containing composition for mucosa administration and its preparation
JPS567720A (en) Antiphlogistic agent
SU1183085A1 (ru) Устройство дл введени лекарственных препаратов
Garner MORPHOLOGICAL AND PHYSIOLOGICAL CORRELATES OF GONADOTROPHIN SECRETION AFTER INTERMITTENT GONADOTROPHIN-RELEASING HORMONE ADMINISTRATION IN THE ADULT MALE RAT (FOLLICLE-STIMULATING, LUTEINIZING, ANTERIOR PITUITARY GLAND)
ATE79277T1 (de) Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids.
FR2360310A1 (fr) Solution antitumorale aqueuse et son procede de preparation
ES8707108A1 (es) Procedimiento para la fabricacion de particulas de polvo micronizadas e hidrofilizadas de una substancia hidrofoga o dificilmente soluble, mezclados con un tensioactivo
IT1226144B (it) Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi.
NZ236497A (en) Percutaneous absorption promoting agent containing a surfactant mixture
GR860428B (en) Controlled release of an active pesticide substance in aqueous solution

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-09-15

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20080916